Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2003
03/06/2003US20030045525 Particularly in the treatment of benign prostatic hyperplasia.
03/06/2003US20030045524 Particularly quinoxaline, (2-imidozolin-2-ylamino) quinoxaline, or 5-bromo-6-(2-imidozolin-2-ylamino) quinoxaline and linolenic acid, which may be complexed with the quinoxaline agonist
03/06/2003US20030045517 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
03/06/2003US20030045479 Novel N-formyl hydroxylamine compounds, compositions and methods of use
03/06/2003US20030044399 Method of treatment
03/06/2003CA2458621A1 Oral antidiabetic agents
03/06/2003CA2458616A1 Aromatic and heteroaromatic acid halides for synthesizing polyamides
03/06/2003CA2457838A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents
03/05/2003EP1287018A2 Thrombin inhibitors
03/05/2003EP1286988A2 1-(h-1,2,4-triazol-1-yl)butan-2-ol derivatives
03/05/2003EP1286987A1 Heterocyclic hydrazones for use as anti-cancer agents
03/05/2003EP1286973A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP1286955A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
03/05/2003EP1286673A2 Ligands of integrin receptors
03/05/2003EP0966447B1 Small molecules useful in the treatment of inflammatory disease
03/05/2003EP0945438B1 Pyrazole derivatives
03/05/2003EP0831830B1 Imidazole compounds
03/05/2003CN1400970A Substituted arylpyrazines
03/05/2003CN1400969A Fused imidazolium derivatives
03/05/2003CN1400898A 回旋酶抑制剂及其用途 Gyrase inhibitors and their use
03/05/2003CN1102593C N-[4(heteroarylmethyl)phenyl]-heteroarylamines compound
03/04/2003US6528661 Providing atorvastatin ester derivative; converting the atorvastatin ester derivative to atorvastatin hemi-calcium with calcium hydroxide
03/04/2003US6528650 Cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing
03/04/2003US6528526 Inhibition of cell proliferation and/or cell matrix production and/or cell movement (chemotaxis) and/or T cell activation and proliferation
03/04/2003US6528513 Viricides; especially cytomegalo virus
03/04/2003US6528509 Pyrazole compositions useful as inhibitors of ERK
03/04/2003US6528505 Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
03/04/2003US6528503 Anticoagulants
03/04/2003CA2218913C Substituted oximes, hydrazones and olefins as neurokinin antagonists
02/2003
02/27/2003WO2003016313A1 New compounds for treating impotence
02/27/2003WO2003016306A1 Hiv inhibiting pyrimidines derivatives
02/27/2003WO2003016305A1 Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof
02/27/2003WO2003016304A1 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
02/27/2003WO2003016286A1 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
02/27/2003WO2003016283A1 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use
02/27/2003WO2003016282A2 Substituted 1h-dihydropyrazoles, their preparation and use
02/27/2003WO2003016276A2 3-substituted oxindole beta-3 agonists
02/27/2003WO2003016275A1 Antiviral agent
02/27/2003WO2003015786A1 2, 5-substituted 1-(aminocarbonylalkyl) -pyrimidin-4-one derivatives with lp-pla2 inhinitory activity for the treatment of atherosclerosis
02/27/2003WO2003015785A1 2h-phthalazin-1-ones and methods for use thereof
02/27/2003WO2003015774A1 Compounds effecting glucokinase
02/27/2003WO2003015769A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments
02/27/2003WO2003015703A2 Compositions and methods relating to novel benzodiazepine compounds and targets thereof
02/27/2003WO2003015608A2 Combination therapy for the treatment of cancer
02/27/2003WO2003015517A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides
02/27/2003WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes
02/27/2003WO2002098865A3 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
02/27/2003WO2002085301A3 Indole, azaindole and related heterocyclic amidopiperazine derivatives
02/27/2003WO2002080853A3 Fused heterocyclic inhibitors of factor xa
02/27/2003WO2002079149A3 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
02/27/2003WO2002074050A3 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor
02/27/2003WO2001098267A8 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity
02/27/2003WO2001097861A3 Vitronectin receptor antagonist pharmaceuticals
02/27/2003US20030040639 Reacting polymer bound chemical intermediate compound with complex to produce complex compound; reacting with nucleophile(s); benzene derivative is decomplexed, optionally derivatised, cleaved from the support
02/27/2003US20030040631 As chemical intermediates used for the preparation of S-alpha-ethyl-2-oxo-1-pyrrolidine acetamide
02/27/2003US20030040608 Having good hue and capable of forming images having high lightfastness
02/27/2003US20030040536 For therapy of disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease
02/27/2003US20030040518 For therapy of neurodegenerative diseases and for the regeneration or prevention of degeneration of lesioned and damaged neurons degeneration of lesioned and damaged neurons
02/27/2003CA2457745A1 Combination therapy for the treatment of cancer
02/27/2003CA2457405A1 Compositions and methods relating to benzodiazepine compounds
02/27/2003CA2457037A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments
02/27/2003CA2456985A1 2h-phthalazin-1-ones and methods for use thereof
02/27/2003CA2456290A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides
02/27/2003CA2454298A1 Substituted 1h-dihydropyrazoles, their preparation and use
02/26/2003EP1285921A1 A process for the preparation of high purity pemirolast
02/26/2003EP1285657A2 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
02/26/2003EP1285653A1 Use of alpha-1L agonists in the treatment of incontinence
02/26/2003EP1284737A1 Water soluble prodrugs of azole compounds
02/26/2003EP1150976B1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
02/26/2003EP0971901B1 Phthalazinones
02/26/2003CN1399635A Piperazing derivatives as 5-HT1B antagonists
02/26/2003CN1399634A Hydroxyalkanoyl aminolactams and related structure as inhibitors of A beta protein production
02/26/2003CN1399631A Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
02/26/2003CN1399573A Use of phthalazine derivatives
02/26/2003CN1399515A Insecticidal and acaricidal agents
02/25/2003US6525215 HIV protease inhibitors
02/25/2003US6525202 Cyclic amine phenyl beta-3 adrenergic receptor agonists
02/25/2003US6525074 Peptidomimetic macrocyclic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras
02/25/2003US6525072 Prevention and treatment of cellular disorders such as cancer
02/25/2003US6525069 Such as N-(t-butyl)-N'-(2-((3-(4-fluorophenyl)methyl)piperi -dinyl)methyl)cyclohexyl)urea; prevention of asthma and other allergic diseases
02/25/2003US6525059 Substituted pyrazoles as p38 kinase inhibitors
02/25/2003US6525054 Cyanoiminoquinoxaline derivatives
02/25/2003US6525052 Compounds useful as reversible inhibitors of cysteine proteases
02/25/2003US6525001 Substituted pyrimidine and pyridine herbicides
02/25/2003US6524553 A compound, comprising: a targeting moiety and a chelator, wherein the targeting moiety is bound to the chelator, is a qinolone nonpeptide, and binds to a receptor that is upregulated during angiogenesis
02/25/2003US6524347 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
02/20/2003WO2003014112A1 Crystal and process for producing the same
02/20/2003WO2003014105A1 Bicyclic compound, production and use as hiv inhibitors
02/20/2003WO2003014092A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
02/20/2003WO2003014083A1 Spiro compounds
02/20/2003WO2003013571A1 Peptidomimetics of biologically active metallopeptides
02/20/2003WO2003013545A1 Novel benzo-fused heterocycles as endothelin antagonisits
02/20/2003WO2003013527A1 Sulfonamide derivatives as gamma secretase inhibitors
02/20/2003WO2003013518A1 Alpha-ketoamide derivatives as cathepsin k inhibitors
02/20/2003WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
02/20/2003WO2002068399B1 Aryl carbamate derivatives, preparation and use thereof
02/20/2003WO2002049993A3 High affinity small molecule c5a receptor modulators
02/20/2003US20030036655 2-(substituted-phenyl)amino-imidazoline derivatives
02/20/2003US20030036650 For use in producing amino acid derivative antibiotics